Related Experiment Video
Updated: Jan 19, 2026
01:09
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
483
Hepatology Clearance for Immunomodulation in Patients With Hepatitis B
Tae Hoon Lee1,2, Thomas D Schiano1,3
1Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York NY.
Clinical Liver Disease
|September 12, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
483
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
483
Hepatic Drug Clearance: Role of Transporters
298
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
298
Hepatic Drug Clearance: Effect of Protein Binding
527
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
527
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
280
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
280
07:10Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
22.5K
Here, we present a protocol for measurement of hepatic venous pressure gradient (HVPG),the gold standard to diagnose clinically significant portal hypertension. Moreover, we describe how to perform a transjugular liver biopsy within the same...
22.5K
09:07Murine Model of Epicutaneously-Induced Immunomodulation
504
The study demonstrates the role of the skin in modulating immune responses in mice through epicutaneous (EC) immunization. EC immunization with a protein antigen can suppress immune responses in contact hypersensitivity or reverse skin-induced suppression when combined with pathogen-associated molecular patterns. EC immunization shows promise as an effective, needle-free approach to...
504
